{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T06:17:48Z","timestamp":1783059468931,"version":"3.54.6"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:00:00Z","timestamp":1625702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Early studies on vaccination of children with oncological diseases were only dedicated to the assessment of safety and immunogenicity of the drug. Mechanisms of the post-vaccination immune response were not investigated. This study involved 41 patients aged 7-15 years who were treated for solid tumors two or more years ago. Of these, 26 were vaccinated against diphtheria and tetanus with ADS-m toxoid. Fifteen children (i.e., controls) were not vaccinated. The vaccination tolerability and clinical characteristics of the underlying disease remission ware assessed. Lymphocyte subpopulations were investigated over time by flow cytometry at 1, 6, and 12 months. IgG anti-diphtheria and anti-tetanus toxoids levels were assessed by ELISA. Within the first day of the post-vaccination period, two (7.7%) children demonstrated moderate local reactions and increased body temperature (up to 38.0\u00b0C). Relapse and metastasis were not mentioned within a year after immunization. An increase in concentration of IgG antibodies, maintained for 12 months, were noted [2.1 (1.3-3.4) IU\/ml against diphtheria (p &amp;lt;0.001), 6.4 (2.3-9.7) IU\/ml against tetanus (p &amp;lt;0.001)]. In contrast to healthy children, those with a history of cancer demonstrated a decrease in the relative number of mature T lymphocytes, as well as in absolute number of cytotoxic T cells and B lymphocytes. In a month after the revaccination, a significant increase in absolute (p = 0.04) and relative (p = 0.007) numbers of T lymphocytes and T helpers was revealed. In a year, these values decreased to baseline levels. As for helpers, they decreased below baseline and control values (p = 0.004). In a year after the vaccination, there was a significant (p = 0.05) increase in lymphocyte level with a decrease in the number of NK cells and B cells as compared with controls. Revaccination against diphtheria and tetanus promoted proliferation of a total lymphocytic cell pool along with restoration of the T lymphocyte subpopulation in children with a history of solid tumors. The ADS-m toxoid has a certain nonspecific immunomodulatory effect. These findings are important, also in the midst of the coronavirus pandemic.<\/jats:p>","DOI":"10.3389\/fimmu.2021.696816","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T07:20:53Z","timestamp":1625728853000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Vaccination Against Diphtheria and Tetanus as a Way to Activate Adaptive Immunity in Children with Solid Tumors"],"prefix":"10.3389","volume":"12","author":[{"given":"Mikhail Petrovich","family":"Kostinov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelli Kimovna","family":"Akhmatova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana Victorovna","family":"Karpocheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Egorovna","family":"Vlasenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina Borisovna","family":"Polishchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton Mikhailovich","family":"Kostinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,8]]},"reference":[{"key":"B1","volume-title":"Vaccination of Children With Impaired Health. Guidelines for Doctors","author":"Kostinov","year":"1996"},{"key":"B2","volume-title":"New in Clinics, Diagnostics and Vaccine Prevention of Controlled Infections","author":"Kostinov","year":"1997"},{"key":"B3","volume-title":"Clinical-Immune Effectiveness of Immune Biological Medicinal Agents: Reference Book","author":"Kostinov","year":"2004"},{"key":"B4","first-page":"1","article-title":"Vaccine Prophylaxis of Respiratory Diseases in the Framework of Primary Health Care","volume":"2","author":"Chuchalin","year":"2015","journal-title":"Clin Guidelines Pulmonol Suppl"},{"key":"B5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s40425-019-0799-2","article-title":"Peripheral Immune-Based Biomarkers in Cancer Immunotherapy: Can We Realize Their Predictive Potential","volume":"7","author":"Nixon","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2020.100476","article-title":"Enhancing Innate Immunity Against Virus in Times of COVID-19: Trying to Untangle Facts From Fictions","volume":"13","author":"Larenas-Linnemann","year":"2020","journal-title":"World Allergy Organ J"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit816","article-title":"2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00457-z","article-title":"T Cell Regeneration After Immunological Injury","volume":"21","author":"Velardi","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nri1781","article-title":"Journey Through the Thymus: Stromal Guides for T-Cell Development and Selection","volume":"6","author":"Takahama","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08478.x","article-title":"Immune Reconstitution in Children Following Chemotherapy for Haematological Malignancies: A Long-Term Follow-Up","volume":"152","author":"van Tilburg","year":"2011","journal-title":"Br J Haematol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.116","article-title":"Leukemia-Free Survival in Myeloid Leukemia, But Not in Lymphoid Leukemia, Is Predicted by Early CD4+ Reconstitution Following Unrelated Cord Blood Transplantation in Children: A Multicenter Retrospective Cohort Analysis","volume":"51","author":"Admiraal","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.2.467","article-title":"Comparison of Immune Reconstitution After Unrelated and Related T-Cell-Depleted Bone Marrow Transplantation: Effect of Patient Age and Donor Leukocyte Infusions","volume":"93","author":"Small","year":"1999","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2016.1265113","article-title":"Early Recovery of T-Cell Function Predicts Improved Survival After T-Cell Depleted Allogeneic Transplant","volume":"58","author":"Goldberg","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2450\/2012.0034-11","article-title":"The Impact of Early CD4+ Lymphocyte Recovery on the Outcome of Patients Who Undergo Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation","volume":"10","author":"Fedele","year":"2012","journal-title":"Blood Transfus"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1096-8652(199702)54:2<131::aid-ajh6>3.0.co;2-y","article-title":"Infectious Morbidity in Long-Term Survivors of Allogeneic Marrow Transplantation Is Associated With Low CD4 T Cell Counts","volume":"54","author":"Storek","year":"1997","journal-title":"Am J Hematol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1513\/pats.200809-113GO","article-title":"Infections Relevant to Lung Transplantation","volume":"6","author":"Remund","year":"2009","journal-title":"Proc Am Thorac Soc"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.9.3481","article-title":"Identification of Patients Who may Benefit From Prophylactic Immunotherapy After Bone Marrow Transplantation for Acute Myeloid Leukemia on the Basis of Lymphocyte Recovery Early After Transplantation","volume":"91","author":"Powles","year":"1998","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.05.015","article-title":"Lymphocyte Recovery Is a Major Determinant of Outcome After Matched Unrelated Myeloablative Transplantation for Myelogenous. Malignancies","volume":"15","author":"Le Blanc","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03135.x","article-title":"Prolonged Immune Deficiency Following Allogeneic Stem Cell Transplantation: Risk Factors and Complications in Adult Patients","volume":"115","author":"Maury","year":"2001","journal-title":"Br J Haematol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00114","article-title":"Mechanisms of Action of Adjuvants","volume":"4","author":"Awate","year":"2013","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1459394","article-title":"Adjuvants: Classification, Modus Operandi, and Licensing","volume":"2016","author":"Apost\u00f3lico","year":"2016","journal-title":"J Immunol Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3109\/10428199309147369","article-title":"Active Immunization of Children With Leukemia and Other Malignancies","volume":"9","author":"Ridgway","year":"1993","journal-title":"Leuk Lymphoma"},{"key":"B23","doi-asserted-by":"crossref","DOI":"10.1542\/peds.74.1.86","article-title":"Antibody Production Following Immunization With Diphtheria and Tetanus Toxoids in Children Receiving Chemotherapy During Remission of Malignant Disease","volume":"74","author":"Kung","year":"1984","journal-title":"Pediatrics"},{"key":"B24","first-page":"432","volume-title":"Vaccination of Children With Impaired Health. Guidelines for Doctors","author":"Kostinov","year":"2013"},{"key":"B25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3346\/jkms.2012.27.1.78","article-title":"Assessment of Serologic Immunity to Diphtheria-Tetanus-Pertussis After Treatment of Korean Pediatric Hematology and Oncology Patients","volume":"27","author":"Kwon","year":"2012","journal-title":"J Korean Med Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.696816\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T09:07:34Z","timestamp":1672736854000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.696816\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,8]]},"references-count":25,"alternative-id":["10.3389\/fimmu.2021.696816"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.696816","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,8]]},"article-number":"696816"}}